Masaaki Ishikawa Selected Research

Masaaki Ishikawa Research Topics

Disease

15	Neoplasms (Cancer) 08/2014 - 05/2004
9	Leukemia 09/2012 - 07/2003
5	B-Cell Leukemia (Leukemia, B Cell) 10/2013 - 05/2008
4	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2010
2	Pain (Aches) 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2014 - 11/2013
2	Lymphoma (Lymphomas) 01/2013 - 12/2005
2	Infections 05/2011 - 03/2002
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2007 - 05/2004
1	Adenoma (Adenomas) 04/2020
1	Ototoxicity 01/2019
1	Hidden Hearing Loss 01/2019
1	Thrombosis (Thrombus) 08/2016
1	Hemophilia B (Haemophilia B) 08/2016
1	Obesity 02/2015
1	Sensorineural Hearing Loss 05/2014
1	Noise-Induced Hearing Loss (Acoustic Trauma) 05/2014
1	Hearing Loss (Hearing Impairment) 05/2014
1	Down Syndrome (Down's Syndrome) 01/2013
1	Cerebral Palsy (Spastic Diplegia) 01/2013
1	Intellectual Disability (Idiocy) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	T-Cell Leukemia (Leukemia, T Cell) 01/2012
1	Carcinogenesis 02/2011
1	Hematuria 01/2011
1	Hemoptysis 01/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Cleft Lip (Harelip) 06/2010

Drug/Important Bio-Agent (IBA)

4	FlavonoidsIBA 01/2012 - 03/2005
4	Pharmaceutical PreparationsIBA 01/2011 - 06/2004
4	AntimetabolitesIBA 11/2007 - 06/2004
4	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2007 - 06/2004
3	papuamineIBA 08/2014 - 01/2013
3	caffeic acidIBA 02/2013 - 12/2005
3	Propolis (Bee Bread)IBA 08/2008 - 05/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2004 - 07/2003
2	EnzymesIBA 02/2015 - 01/2011
2	Docosahexaenoic AcidsIBA 01/2015 - 02/2011
2	caffeic acid undecyl esterIBA 10/2013 - 02/2013
2	EstersIBA 10/2013 - 08/2008
2	AlbuminsIBA 01/2013 - 02/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2012 - 05/2012
2	spiruchostatin BIBA 09/2012 - 05/2012
2	Histone Deacetylase InhibitorsIBA 09/2012 - 05/2012
2	AntioxidantsIBA 01/2012 - 08/2008
2	cytochrome P-450 CYP4B1 (CYP4B1)IBA 01/2011 - 09/2008
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2011 - 02/2008
2	3,4,5-trihydroxybenzamidoximeIBA 03/2008 - 05/2007
2	naringeninIBA 10/2006 - 03/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006 - 01/2006
2	naringinIBA 01/2006 - 03/2005
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	apramycinIBA 01/2019
1	gentamicin CIBA 01/2019
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2019
1	AminoglycosidesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Neomycin FDA LinkGeneric 01/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019
1	Hemostatics (Antihemorrhagics)IBA 08/2016
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 08/2016
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 02/2015
1	pifithrinIBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014
1	JNK Mitogen-Activated Protein KinasesIBA 08/2014
1	calpain inhibitor IIIIBA 05/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2013
1	caffeic acid phenethyl esterIBA 02/2013
1	Midazolam (Versed)FDA LinkGeneric 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2013
1	ChromatinIBA 01/2013
1	Propofol (Diprivan)FDA LinkGeneric 01/2013
1	AlkaloidsIBA 01/2013
1	AndrogensIBA 01/2013
1	Warfarin (Coumadin)FDA LinkGeneric 01/2013
1	Nitrous Oxide (Laughing Gas)IBA 01/2013
1	haliclonadiamineIBA 01/2013
1	Messenger RNA (mRNA)IBA 05/2012
1	acacetinIBA 01/2012
1	CaspasesIBA 01/2012
1	Fish OilsIBA 02/2011
1	AcidsIBA 02/2011
1	Small Interfering RNA (siRNA)IBA 02/2011
1	Factor V (Coagulation Factor V)IBA 01/2011
1	CarcinogensIBA 01/2011
1	glutathione S-transferase M1IBA 01/2011
1	glutathione S-transferase T1IBA 01/2011
1	SulfotransferasesIBA 01/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 08/2014 - 11/2007
1	Tonsillectomy 01/2022
1	Reoperation 04/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2016
1	Perioperative Period 08/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2016
1	Therapeutics 08/2016
1	Thyroidectomy 06/2011
1	Replantation 05/2011
1	Nasoalveolar Molding 06/2010